TOKYOMEDIJAPAN MEDICAL REFERENCE
⌕ Veritabanında araResmi kaynak · PMDA / MHLW
JAPON İLAÇLARI · BİRİNCİL KAYNAKLAR · JAPONYA’DA BAKIM

Japon ilaçları ve Japonya’da tedavi için referans bilgileri

Japon ürün adları, jenerik adlar, ruhsat sahipleri, dozlar ve PMDA ürün düzeyi kaynakları, uluslararası hastalar için hastanelerin resmi kabul bilgileriyle birlikte düzenlenir. Reçeteli ilaçlar lisanslı sağlık profesyoneli değerlendirmesi ve uygun klinik süreci gerektirir.

Primary sources firstThree-language structureNo direct Rx sales
Primary verification sources
PMDARegulation / SafetyMHLWPolicy / Health systemRAD-ARPatient medicine information
01 · SOURCES & VERIFICATION

Sources and verification

Medicine and medical-travel information is presented with sources, verification dates and scope.

PMDA

Official medicine sources

Japanese product names, manufacturers and strengths are matched to PMDA product-level records.

HOSPITAL

Official hospital information

Appointments, referrals, coordinators and language requirements are checked against hospital sources.

DATES

Document and verification dates

Official document dates and TOKYO MEDI verification dates are shown separately.

BOUNDARY

Scope of medical information

No remote prescribing and no ordinary ecommerce flow for prescription medicines.

03 · MEDICINE DATABASE

Japon ilaç referansı

Japon ürün adı, jenerik ad, ruhsat sahibi, doz, tedavi alanı ve birincil kaynağa göre düzenlenir.

04 · HEALTH & NUTRITION

Sağlık ve beslenme

Sağlık gıdaları ve takviyeler ilaçlardan ayrı tutulur; gıda statüsü, paket boyutu ve ürün kaynakları açıkça belirtilir.

Health foods and supplements are kept separate from medicines and are not presented as medicines.

Browse health & nutrition →
05 · EDITORIAL POLICY

Editoryal ilkeler

Medicine records are organized from product-level official sources. Medical-travel content is limited to official hospital intake and system information. TOKYO MEDI does not provide personal medical consultation, appointments, diagnosis, prescribing or care coordination.

Resmi kaynak →
01

Primary sources first

Medicine status and hospital intake information are anchored to regulators, manufacturers and medical institutions.

02

Medical information separated from commerce

Prescription pages support reference and care pathways rather than ordinary shopping flows.

03

Organized for international readers

Multilingual names, Japanese system context and overseas-patient intake requirements are organized together.

04

Sources and verification dates shown

Official document dates and site verification dates are separated so readers can judge source and recency.

07 · MEDICAL TRAVEL INFORMATION

Japonya’da tedavi

Tümünü gör →
Tokyo
TOKYO / JAPANConfirm the medical need, hospital intake requirements and appointment route before arranging care.
08 · INSTITUTIONAL INQUIRY

Institutional medicine inquiry

For institutions, pharmacies and companies only. Please provide institution details, medicine and strength, quantity, destination and relevant credentials. Personal prescription-medicine purchase requests and medical consultations are not accepted.

ForInstitutions / pharmacies / companiesRequiredItem / strength / quantity / destination / credentialsKurumsal sorgu gönder
09 · PRESCRIPTION REFERENCE

Reçeteli ilaç referansı

Tümünü gör →
Norvasc · Amlodipineノルバスク錠2.5mg/5mg/10mg・ノルバスクOD錠2.5mg/5mg/10mg · ヴィアトリス製薬合同会社Mainly used for high blood pressure and angina.
KardiyovaskülerRx
Opdivo · Nivolumabオプジーボ点滴静注20mg/100mg/120mg/240mg · 小野薬品工業株式会社Used for selected cancers, including melanoma, lung and kidney cancer, under disease-specific conditions.
OnkolojiRx
Keytruda · Pembrolizumabキイトルーダ点滴静注100mg · MSD株式会社Used for selected cancers such as melanoma and lung cancer, depending on cancer type, stage or biomarkers.
OnkolojiRx
Tagrisso · Osimertinibタグリッソ錠40mg/80mg · アストラゼネカ株式会社Used for certain EGFR mutation-positive non-small-cell lung cancers.
OnkolojiRx
Enhertu · Trastuzumab deruxtecanエンハーツ点滴静注用100mg · 第一三共株式会社Used for selected breast, stomach, lung and other solid cancers meeting specific HER2 criteria.
OnkolojiRx
Leqembi · Lecanemabレケンビ点滴静注200mg/500mg · エーザイ株式会社Used to slow progression of mild cognitive impairment or mild dementia due to Alzheimer’s disease.
NörolojiRx
Entresto · Sacubitril / valsartanエンレスト錠50mg/100mg/200mg・粒状錠小児用12.5mg/31.25mg · ノバルティスファーマ株式会社Mainly used for chronic heart failure; some strengths are also approved for hypertension.
KardiyovaskülerRx
Jardiance · Empagliflozinジャディアンス錠10mg/25mg · 日本ベーリンガーインゲルハイム株式会社Used for type 2 diabetes; the 10 mg product is also used for certain chronic heart failure and kidney disease.
MetabolikRx
PRESCRIPTION MEDICINEPrescription pages provide product and primary-source information only. Suitability, prescribing and use are determined by clinicians and pharmacists.
Browse medicine reference →